Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
The BioSpace 40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI-driven analytics and Ohio’s gene therapy ecosystem—with a responsibility to patients worldwide.
comments(0)
5-min edit window · permanent after that